Urovant Sciences Ltd. — Net Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/78e61eca-4461-4d13-b178-53472c351ba0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-146.7M | 2019-04-01 – 2020-03-31 | evidence 0001564590-20-029968 |
| FY 2018 | $-111.3M | 2018-04-01 – 2019-03-31 | evidence 0001564590-19-022570 |
| FY 2017 | $-37.1M | 2017-04-01 – 2018-03-31 | evidence 0001564590-19-022570 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).